Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy
about
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic VirusesPromising oncolytic agents for metastatic breast cancer treatmentRole of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance.Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional ProgramIntratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer.Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy.Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer.Oncolytic viruses and their application to cancer immunotherapyRobust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model.N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cellsSTAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells.Macrophage response to oncolytic paramyxoviruses potentiates virus-mediated tumor cell killing.Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.Oncolytic Immunotherapy for Treatment of Cancer.Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms.Comparative protein profiling of B16 mouse melanoma cells susceptible and non-susceptible to alphavirus infection: Effect of the tumor microenvironment.Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virus.Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response.Tumor Restrictions to Oncolytic Virus.CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.
P2860
Q26767212-8DD56FD4-1BDC-4758-B480-56B790565B37Q26830620-2F450106-A8F0-4908-8825-86B0733CD6E8Q35618563-57477030-B97C-45F6-AF52-C30AE94B5CAEQ36427920-B1289C73-A38C-4CAD-83FD-D76BA81D20C4Q36664277-170FC69F-0652-4E2B-B387-1EECED50842FQ37292354-F32C39A8-4050-471F-9910-86C045CCB695Q37625385-B69D0D20-75E1-46AD-8C49-18F89F7E2757Q38207011-A8ACD216-C417-4484-A8EC-ACE1F5C58990Q38734741-5A9E0F10-B461-4D9D-A2F9-28D2180EC6B7Q38746434-41B09FE8-E744-4F6C-B24D-EF17E3EDC898Q38793802-EF275852-6C9A-4DEA-989F-03B135062F31Q38804011-778A9460-5624-4B4C-9CD3-B6AE41BC1A14Q38817649-A9E1348C-E180-4BB0-A111-4F66B05328FFQ38848223-10BA274F-0C7A-4E93-A342-43FDDB290365Q39109430-39DEB963-771A-4D7D-8967-D6731F712737Q40071126-F08C9FB5-03DA-4B47-99F1-B83F6CF4025CQ40537831-F6C87880-0A94-4E7C-AB40-A5B22D41E4B0Q41903358-B021C6D4-CA19-4FA9-8A79-261803D21FCAQ47563785-F7BD729B-B933-4F09-A109-5B34CDFFF962Q51846287-2E3E7155-3623-4951-97B6-EADF59F9BC1EQ52645848-989C5A7A-818F-44BB-9EFE-72C3D3585B6DQ52769260-81661E39-6BEE-4C5E-B0A8-6409F13C9D57Q53122691-4A30A8B4-C105-4883-A003-AC3ADB633E1BQ55053341-61E34118-58A3-4BB4-8E29-599CDF72E690
P2860
Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Induction of antiviral genes b ...... fers resistance to virotherapy
@en
Induction of antiviral genes b ...... ers resistance to virotherapy.
@nl
type
label
Induction of antiviral genes b ...... fers resistance to virotherapy
@en
Induction of antiviral genes b ...... ers resistance to virotherapy.
@nl
prefLabel
Induction of antiviral genes b ...... fers resistance to virotherapy
@en
Induction of antiviral genes b ...... ers resistance to virotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Induction of antiviral genes b ...... fers resistance to virotherapy
@en
P2093
Lukkana Suksanpaisan
Michael B Steele
Yu-Ping Liu
P2860
P2888
P356
10.1038/SREP02375
P407
P577
2013-01-01T00:00:00Z